Stock Ticker

  • Loading stock data...

Pfizer Inc.’s (NYSE:PFE) Transforming Into An Integrated and Collaborative Intelligence Company

Over the past decade, Pfizer Inc.’s (NYSE:PFE) data science senior director Chris Kakkanatt has been transforming the company into a collaborative and integrated intelligence entity. This idea has made headlines for years, and with the proliferation of advances and data in machine learning, the objective has become necessary for most organizations. Kakkanatt shared the transformation […]

The Virus Testing Boom is Upon Us (CODX, DGX, RXMD, LH)

Trump even said it himself on Tuesday: “It’s going to get worse before it gets better.” We keep hitting new highs among coronavirus infections, hospitalization, and related deaths. New hot spots keep popping up. Mississippi appears to be the latest. The positivity rate in Arizona continues to be in the 20-40% range, which smacks of […]

OPKO Health’s (NASDAQ:OPK) BioReferences Laboratories Announce COVID-19 Molecular PCR Testing Results In Nursing Home Employees

OPKO Health’s (NASDAQ:OPK) BioReferences Laboratories released results of the coronavirus molecular PCR and antibody tests for the live-in facility and nursing home employees in New York. Around 29% of nursing home staff had COVID-19 before May On May 10, 2020, the state of New York directed all employees in adult care facilities and nursing homes […]

Abbvie Inc (NYSE:ABBV) And Alpine Immune Sciences Inc. (NASDAQ:ALPN) Enter Partnership To Develop ALPN-101

Abbvie Inc (NYSE:ABBV) and Alpine Immune Sciences Inc. (NASDAQ:ALPN) have announced an exclusive global license and option agreement for Alpine’s best in class dual ICOS/CD28 costimulation antagonist, ALPN-101. AbbVie to co-develop ALPN-101 with Alpine ICOS and CD28 are important costimulatory molecules playing critical roles in inflammatory autoimmune diseases. Alpine’s ALPN-101 is a potent ICOS and […]

Eli Lilly And Co (NYSE:LLY) Commences First Human Trial Involving Its Antibody-based COVID-19 Treatment

Eli Lilly And Co (NYSE:LLY) revealed on Monday that it started testing human subjects with its developmental treatment for COVID-19, which is based on antibodies. The biopharma is currently working on phase 1 of the clinical trial, through which it aims to test the safety and efficacy of the drug. Eli Lilly plans to publish […]

Gilead Sciences, Inc. (NASDAQ:GILD) Reports Minor Benefits Of Remdesivir In COVID-19 Patients

Gilead Sciences, Inc. (NASDAQ:GILD) released an update about its developmental COVID-19 vaccine remdesivir, revealing that the treatment yielded modest improvements in patients. Coronavirus patients who were administered with remdesivir intravenously for five days demonstrated moderate improvements. However, the COVID-19 patients that were treated with the drug for 10-days did not yield significant improvements. Remdesivir was […]

Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul

Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock price, but the announcement also yielded some criticism. The U.S-based biotech revealed that the initial results of its coronavirus vaccine were promising. This was enough to encourage positive sentiments regarding […]

Novavax, Inc (NASDAQ:NVAX) Chooses Australia For Its COVID-19 Clinical Trials

The deadly COVID-19 pandemic continues to affect lives globally, with many people hardly affording to pay their house rent. It is frustrating that until no scientific cure to help handle the condition has been established yet. However, any good efforts mean a lot to frustrated people globally. There are reports about another candidate that is […]

Is the PPE Theme Ready to Catch Fire? (APT, LAKE, BLGO, MMM)

The COVID-19 pandemic has forced a reimagining of life in the developed world to a far greater extent than most anything since World War II. As we endure this collective battle, there are few subjects that spark populist anger more than personal protection equipment (PPE) and its lack of availability for frontline workers – not […]

Moderna Inc. (NASDAQ:MRNA) Releases Positive Data For Its Coronavirus Vaccine Candidate In Human Trials

Moderna Inc. (NASDAQ:MRNA) has released positive data from its first human trials for its COVID-19 vaccine candidate, demonstrating that the healthy volunteers who received the vaccine developed antibody responses. Moderna’s vaccine in humans shows positive immunity response The company which had partnered with the National Institute of Health in developing the vaccine indicated that there […]

Abbott Laboratories’ (NYSE:ABT) ID NOW test May Be Giving Inaccurate Test Results Due To “User Error”

The US FDA has warned that Abbott Laboratories’ (NYSE:ABT) rapid COVID-19 test might be having accuracy issues that might be due to user error. The FDA cited various studies that have raised concerns about the test’s accuracy when employed in making a quick diagnosis. Abbott’s rapid test could be giving inaccurate results Alex Azar, the […]

The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)

The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has priority. It’s not a genuine public debate – if you don’t solve the healthcare crisis, you can’t solve any of the other crises that have been boiling over in the public discourse. That […]

Gilead Sciences, Inc (NASDAQ:GILD) Speaks Out On The Trial Of Its Remdesivir Drug

Gilead Sciences, Inc (NASDAQ:GILD) is pleased to report about the success it is witnessing with its vaccine Remdesivir. The scientists have been working on the product in the hope that it would turn out to be the vaccine that would possibly help in dealing with COVID-19. Gilead has given an update outlining that it is […]

Gilead Sciences’ (NASDAQ:GILD) Potential COVID-19 Treatment Can Not Undo Damage On The US Economy

Gilead Sciences (NASDAQ:GILD) has a promising COVID-19 cure called remdesivir which caused US equity markets to surge on Friday. However, the surge in the stock market on Friday isn’t something justifiable. Is the economy gearing for fake markets? For stock markets, it has been a gloomy past few weeks and the economy could receive a […]

Sign Up To Get Our Latest Stocks Alerts